Skip to the main content

Erratum

https://doi.org/10.11613/BM.2023.031201

Corrigendum to: Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience

Marija Gomerčić Palčić ; School of Medicine, University of Zagreb, Zagreb, Croatia
Hana Matijaca ; Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Hematology, Zagreb, Croatia
Ivan Kruljac ; Solmed Group, Department: Poliklinika Solmed, Zagreb, Croatia
Lucija Vusić
Vedran Hostić ; Department of Anesthesiology, Intensive Care Medicine and Pain Management, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Luka Vrbanić ; Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Pulmonology, Zagreb, Croatia
Fanika Mrsić ; Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Clinical Immunology and Rheumatology, Zagreb, Croatia
Radovan Zrilić ; Polyclinic for Respiratory Diseases, Dom zdravlja Zagreb - Zapad, Zagreb, Croatia
Ivana Ćelap ; Department of Clinical Chemistry, Sestre milosrdnice University Hospital Center, Croatia
Petar Gaćina ; Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Hematology, Zagreb, Croatia


Full text: english pdf 35 Kb

page 359-360

downloads: 124

cite

Download JATS file


Abstract

Keywords

Hrčak ID:

308778

URI

https://hrcak.srce.hr/308778

Publication date:

15.10.2023.

Visits: 403 *



This is a correction of Biochem Med (Zagreb) 2023;33(2):020704. DOI: https://doi.org/10.11613/BM.2023.020704

Since the publication of the article, the authors have noticed that their first names and surnames in the by-line were listed in reverse. The correct by-line is presented above. We apologize to the authors for any inconvenience caused to the readers.


This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.